Drugs / MV-ZIKA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02996890 | May 2017 → Jan 2018 | Zika virus infectious disease | Themis Bioscience GmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MV-ZIKA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02996890 ↗ |
| Modality | Vaccine | “a New Vaccine Against Zika Virus” NCT02996890 ↗ |